Gluskin Sheff & Assoc Inc Abb Vie Inc. Transaction History
Gluskin Sheff & Assoc Inc
- $739 Million
- Q1 2025
A detailed history of Gluskin Sheff & Assoc Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Gluskin Sheff & Assoc Inc holds 13,980 shares of ABBV stock, worth $2.65 Million. This represents 0.4% of its overall portfolio holdings.
Number of Shares
13,980
Previous 15,192
7.98%
Holding current value
$2.65 Million
Previous $2.7 Million
8.52%
% of portfolio
0.4%
Previous 0.34%
Shares
12 transactions
Others Institutions Holding ABBV
# of Institutions
4,268Shares Held
1.27BCall Options Held
18.2MPut Options Held
15.5M-
Vanguard Group Inc Valley Forge, PA174MShares$33 Billion0.68% of portfolio
-
Black Rock Inc. New York, NY136MShares$25.9 Billion0.54% of portfolio
-
State Street Corp Boston, MA80MShares$15.2 Billion0.71% of portfolio
-
Jpmorgan Chase & CO New York, NY54.8MShares$10.4 Billion0.9% of portfolio
-
Morgan Stanley New York, NY41.1MShares$7.8 Billion0.63% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $335B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...